Mobile HIV testing program removes barriers to testing in Sub-Saharan Africa

July 14, 2004

A voluntary counseling and testing (VCT) program using a mobile van to travel to marketplaces in townships and villages overcomes the structural barriers to HIV testing in Sub-Saharan Africa, according to UCSF researchers.

"Mobile VCT eliminates the cost and inconvenience of having to travel to urban centers for HIV testing, while the presence of the mobile van with outreach workers in busy marketplaces creates familiarity with the testing process and reduces the stigma associated with this process, a significant psychological barrier to testing," said study lead author, Gertrude Khumalo-Sakutukwa, MSW, M Med Sc, an academic specialist at the UCSF AIDS Policy Research Center.

Khumalo-Sakutukwa presented the findings at the XV International AIDS Conference in Bangkok, Thailand on July 14.

A mobile testing van traveled to six marketplaces in villages and townships in Epworth and Seke, Zimbabwe on a rotating basis offering free VCT using rapid HIV tests and same-day results. Researchers had identified the cost of paying for an HIV test and the cost and inconvenience of traveling to the city as the significant structural barriers to testing.

The major psychological barriers identified by the researchers included social stigma associated with being seen going into an HIV testing site, assumption that testers have HIV or AIDS, and fear of learning that one did indeed have HIV. Researchers addressed these concerns by creating a community advisory board (CAB) before testing started and having CAB members engage the community, creating awareness and generating discussions about HIV and testing. The rotating presence of the mobile VCT van in crowded marketplaces became the talk of the community, leading to increased familiarity and diminished stigma.

"Two elements of mobile VCT should be noted. One is the acceptance of rapid tests, and participants liked getting their results the same day and had no doubts that the results were theirs because the blood samples were not sent away for a week. Second, it is important to provide post-test support services including post-test clubs that include both negative and positive test-takers and linkages to medical, psychosocial, and spiritual services for those who test positive," said study co-author, Stephen F. Morin, PhD, director, UCSF AIDS Policy Research Center.
-end-
Co-authors on the study are Janell Routh, MD, resident in the UCSF Department of Pediatrics; Agnès Fiamma, MPH, project director, Tim Lane, PhD, MPH, fellow, both at the UCSF AIDS Policy Research Center; and Katherine Fritz, MPH, PhD, assistant professor of medicine at the UCSF Center for AIDS Prevention Studies.

This study was funded by the UCSF AIDS Research Institute and the Office of AIDS Research and the National Institute of Mental Health at the National Institutes of Health. The project was developed in collaboration with the HIV Prevention Trials Network.

The AIDS Policy Research Center is a component of the UCSF AIDS Research Institute (ARI). UCSF ARI houses hundreds of scientists and dozens of programs throughout UCSF and affiliated labs and institutions, making ARI one of the largest AIDS research entities in the world.

University of California - San Francisco

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.